Osaka, Japan

Takuya Seko

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Ono Pharmaceutical Co., Ltd., Ono Pharmaceuticals Co., Ltd.. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuya Seko. Retrieved from https://idiyas.com/inventor/takuya-seko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 25.0


 

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 167(Granted Patents)


Location History:

  • Mishima-gun, JP (2007)
  • Osaka, JP (1997 - 2012)

Company Filing History:


Years Active: 1997-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Amino Acid Derivatives
LPA Receptor Antagonist
Fused Pyridazine Derivative
Chronic Disease Remedy
Carboxylic Acid Derivatives
Prostaglandin Derivatives
N-Carbamoyl Nitrogen Compounds
Five Membered Heterocyclic Compounds
2H-Phthalazin-1-One Derivatives
Pharmaceutical Composition
Active Ingredients
Drug Development
16 patents (USPTO):Explore Patents

Title: Takuya Seko: Innovator in Medical Chemistry

Introduction

Takuya Seko is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical chemistry, particularly in the development of compounds that target various diseases. With a total of 16 patents to his name, Seko's work has the potential to impact numerous medical conditions.

Latest Patents

One of Seko's latest patents involves an LPA receptor antagonist, which is a compound designed to engage in LPA receptor bonding and antagonism. This compound is useful in the prevention and treatment of a wide range of diseases, including urinary system diseases, carcinoma-associated diseases, proliferative diseases, inflammation and immune system diseases, diseases caused by secretory dysfunction, brain-related diseases, and chronic diseases. The versatility of this compound highlights Seko's innovative approach to addressing complex medical challenges.

Career Highlights

Throughout his career, Takuya Seko has worked with notable companies, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Seko has collaborated with esteemed colleagues such as Masashi Kato and Shinji Nakade. These partnerships have fostered an environment of innovation and have led to the development of impactful medical solutions.

Conclusion

Takuya Seko's contributions to medical chemistry through his patents and collaborations demonstrate his commitment to advancing healthcare. His innovative work continues to pave the way for new treatments and therapies that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…